Arkema Sa · EURONEXT:AKE

Arkema Sa — Q3 2012 Earnings Presentation

13 slides from Arkema Sa's earnings presentation, 2012

  1. Slide 1: 3rd quarter 2012 results

    3rd quarter 2012 results Thierry LEMONNIER CFO

  2. Slide 2: A strong performance reflecting Arkema's robustness

    A strong performance reflecting Arkema’s robustness Sales (€m) € 1,606m sales, +1% vs 3Q’11 1,587 1,606 € 266m EBITDA and 16.6% EBITDA margin ● Same level as 3Q’11 in a less favorable economic environment ● 19.5% in Performance Products with record EBITDA in a third quarter (€107m) 3Q’11 3Q’12 ● 16.

  3. Slide 3: Key drivers of Arkema 3Q'12 performance

    Key drivers of Arkema 3Q’12 performance Challenging market conditions vs 3Q’11 ● Contrasted market conditions by region with challenging conditions in Europe and relatively slow growth in Asia (positive exception in South East Asia) ● Slowdown in demand in certain end markets in September (automotiv

  4. Slide 4: Highlights since July 1st, 2012

    Highlights since July 1st, 2012 Major achievements in portfolio transformation ● Divestment of Vinyl business finalized early July (€1bn sales) ● Divestment of tin stabilizers business finalized early October (€180m sales) ● Acquisition by Coatex of an acrylic additives and emulsion production site

  5. Slide 5: Sales bridge

    Sales bridge Sales (€bn) FX rate – Volume Scope of translation effect Price business 1,587 (2.4)% +5.3% 1,606 (4.5)% +2.8% ● Slowdown in ● Decrease, as ● Hipro/Casda certain end expected, in markets in ● Seppic Acrylic Acid alkoxylates September and HFC-125 in China 3Q’11 3Q’12 5

  6. Slide 6: 3Q'12 key figures

    3Q’12 key figures In €m (except EPS) 3Q’11 3Q’12 variation Sales 1,587 1,606 +1.2 % EBITDA 266 266 = EBITDA margin 16.8% 16.6% Recurring operating income 198 189 -4.5 % Net income (group share) 109 116 +6.4% Adjusted EPS (diluted) 2.09 1.88 -10.0% 6

  7. Slide 7: Performance Products

    Performance Products In €m 3Q’11 3Q’12 variation Sales 519 548 +5.6 % EBITDA 102 107 +4.9 % EBITDA margin 19.7% 19.5% Recurring operating income 78 80 +2.6 % +6% sales at €548m ● Benefits from acquisitions (bio-based polyamide 10 in China and alkoxylates) ● Slowdown in demand in September in automot

  8. Slide 8: Industrial Chemicals

    Industrial Chemicals In €m 3Q’11 3Q’12 variation Sales 1,063 1,053 -0.9 % EBITDA 175 176 +0.6 % EBITDA margin 16.5% 16.7% Recurring operating income 132 127 -3.8 % Stable volumes despite weak automotive in Europe and low demand in deco paints Decrease, as expected, of acrylic acid and fluorogases pr

  9. Slide 9: Three new reporting segments

    Three new reporting segments High Performance Materials Industrial Specialties Coating Solutions Solutions for decorative paints, World of high value and Global and integrated industrial coatings and innovative solutions industrial niches high-growth acrylic applications ● Specialty polyamides ● Thi

  10. Slide 10: Contribution by new reporting segment

    Contribution by new reporting segment High Performance Industrial Coating Solutions Materials Specialties 548 557 Sales (€m) 496 EBITDA (€m) and 19.5% 19.8% EBITDA margin (%) 14.0% 107 98 78 10

  11. Slide 11: 3Q'12 cash flow and net debt end of September

    3Q’12 cash flow and net debt end of September +€ 144m free cash flow* in 3Q’12 includes: ● € 76m recurring capex ● € 81m cash inflow from working capital € 59m cash outflow from M&A ● Payment to Hipro-Casda minority shareholders ● €35m cash out of part of the expenses related to Vinyls divestment bo

  12. Slide 12: FY'2012 outlook confirmed

    FY’2012 outlook confirmed Contrasted macro-economic conditions ● Soft demand observed in certain end markets should continue until year end ● Challenges remain in several European countries ● Volatility of raw material costs ● Customers should cautiously manage their inventories at year-end Traditio

  13. Slide 13: Disclaimer

    Disclaimer The information disclosed in this document may contain forward-looking statements with respect to the financial condition, results of operations, business and strategy of Arkema. Such statements are based on management’s current views and assumptions that could ultimately prove inaccurate

Arkema — Q3 2012 Earnings Presentation on 6ix